biosimilar

American  

[bahy-oh-sim-uh-ler] / ˌbaɪ oʊˈsɪm ə lər /

noun

1. a biopharmaceutical that is very similar, but not identical, to a previously manufactured one.

   Do the biosimilars require fewer clinical trials?

---

adjective

1. of or relating to biopharmaceuticals that closely resemble previously manufactured ones.

   biosimilar products; biosimilar medicine.

Etymology

Origin of biosimilar

First recorded in 2000–05; bio(pharmaceutical) ( def. ) + similar ( def. )

Example Sentences

The South Korean biosimilar company’s operating profit could jump 42% to 1.657 trillion won, with revenue up 26%, this year, the DB analyst writes in a note.

From The Wall Street Journal • Mar. 17, 2026

Stock rose 6.4% after the company bumped up its revenue guidance thanks to growth in its biosimilar product range.

From The Wall Street Journal • Mar. 2, 2026

Swiss drugmaker Sandoz shares jumped after the company bumped up its revenue guidance thanks to growth in its biosimilar product range.

From The Wall Street Journal • Feb. 25, 2026

Related to that, we are going to have the mother of all generic and biosimilar drug cycles from 2026 to 2036.

From Barron's • Jan. 9, 2026

Competitors are expected to launch biosimilar versions of the drug in 2028, and analysts see Keytruda sales dropping 14% in 2029, and 19% in 2030.

From Barron's • Oct. 29, 2025